Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization

Tomany SC, 2004, Risk factors for incident age-related macular degeneration: pooled findings from 3 continents, Ophthalmology, 111, 1280, 10.1016/j.ophtha.2003.11.010 Ryskulova A., 2008, Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 national health interview survey, Am. J. Public Health, 98, 454, 10.2105/AJPH.2006.098202 Ferris FL, 1984, Age-related macular degeneration and blindness due to neovascular maculopathy, Arch. Ophthalmol., 102, 1640, 10.1001/archopht.1984.01040031330019 Brown DM, 2009, ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study, Ophthalmology, 116, 57, 10.1016/j.ophtha.2008.10.018 CATT Research Group, M. D., 2011, Ranibizumab and bevacizumab for neovascular age-related macular degeneration, N. Engl. J. Med., 364, 1897, 10.1056/NEJMoa1102673 Tufail, 2010, ABC Trial Investigators. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study, Br. Med. J., 340, 10.1136/bmj.c2459 WR, 1999, Histopathology of age-related macular degeneration, Mol. Vis., 27 JG., 2010, Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture, Invest. Ophthalmol. Vis. Sci., 51, 1275 Fishel ML, 2007, The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target, Mol. Asp. Med., 28, 375, 10.1016/j.mam.2007.04.005 Luo M, 2008, Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1, Antioxid. Redox Signal, 10, 1853, 10.1089/ars.2008.2120 Tell G, 2009, The many functions of APE1/Ref-1: not only a DNA repair enzyme, Antioxid. Redox Signal, 11, 601, 10.1089/ars.2008.2194 Bhakat KK, 2009, Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein, Antioxid. Redox Signal, 11, 621, 10.1089/ars.2008.2198 Evans AR, 2000, Going APE over ref-1, Mutat. Res., 461, 83, 10.1016/S0921-8777(00)00046-X Wilson DM, 2001, The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA, Mutat. Res., 485, 283, 10.1016/S0921-8777(01)00063-5 Tell G, 2005, The intracellular localization of APE1/Ref-1: more than a passive phenomenon?, Antioxid. Redox Signal, 7, 367, 10.1089/ars.2005.7.367 Kelley M.R., 2012, APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1, Curr. Mol. Pharmacol., 5, 36, 10.2174/1874467211205010036 Ando K, 2008, A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity, Nucleic Acids Res., 36, 4327, 10.1093/nar/gkn416 Zou GM, 2009, The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis, J. Cell. Physiol., 219, 209, 10.1002/jcp.21666 Xanthoudakis S, 1992, Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme, EMBO J., 11, 3323, 10.1002/j.1460-2075.1992.tb05411.x Xanthoudakis S, 1992, Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity, EMBO J., 11, 653, 10.1002/j.1460-2075.1992.tb05097.x Jayaraman L, 1997, Identification of redox/repair protein Ref-1 as a potent activator of p53, Genes Dev., 11, 558, 10.1101/gad.11.5.558 Xanthoudakis S, 1994, The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains, Proc. Natl. Acad. Sci. U. S. A., 91, 23, 10.1073/pnas.91.1.23 Zhang, 2013, Inhibition of apurinic/apyrimidinic endonuclease I׳s redox activity revisited, Biochemistry, 52, 2955, 10.1021/bi400179m Shimizu, 2000, High-performance affinity beads for identifying drug receptors, Nat. Biotechnol., 18, 877, 10.1038/78496 Hiramoto, 1998, Nuclear targeted suppression of NF-κB activity by the novel quinone derivative E3330, J. Immunol., 160, 810, 10.4049/jimmunol.160.2.810 Nyland, 2010, Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1), J. Med. Chem., 53, 1200, 10.1021/jm9014857 Wang, 1999, Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor, Invest. Ophthalmol. Vis. Sci., 40, 477 Kaarniranta K, 2009, NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD), Exp. Gerontol., 44, 685, 10.1016/j.exger.2009.09.002 Arjamaa, 2009, Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD), Ageing Res. Rev., 8, 349, 10.1016/j.arr.2009.06.002 Jonas, 2010, Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration, Arch. Ophthalmol., 128, 1281, 10.1001/archophthalmol.2010.227 Raoul, 2010, CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration, J. Neuroinflamm., 87 Jiang, 2011, Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo, Vis. Res., 51, 93, 10.1016/j.visres.2010.10.008 Qiao, 2012, Selective blocking of APE1/Ref-1 redox function by a novel compound, APX3330 inhibits choroidal endothelial cells in vitro and choroidal neovascularization in vivo, Abstr. Assoc. Res. Vis. Ophthalmol., 342 Yan T., C.M., Zacharek A., Ning R., Qiao X., Kelley M.R., Roberts C., Chen J., Neurorestorative therapy for stroke in type one diabetic rats using APX3330, JCBFM Meeting, 2013. O., 2005, The retinal pigment epithelium in visual function, Physiol. Rev., 85, 845, 10.1152/physrev.00021.2004 Simó, 2010, The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier – implications for the pathogenesis of diabetic retinopathy, J. Biomed. Biotechnol., 190724 Roth, 2004, Key pathophysiologic pathways in age-related macular disease, Graefes Arch. Clin. Exp. Ophthalmol., 242, 710, 10.1007/s00417-004-0976-x Ruberti, 2003, Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch׳s membrane, Invest. Ophthalmol. Vis. Sci., 44, 1753, 10.1167/iovs.02-0496 Mettu, 2012, Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration, Mol. Asp. Med., 33, 376, 10.1016/j.mam.2012.04.006 Yamada, 2008, Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells, J. Neurochem., 105, 1187, 10.1111/j.1471-4159.2008.05211.x Kim, 2012, Oxidized low density lipoprotein-induced senescence of retinal pigment epithelial cells is followed by outer blood-retinal barrier dysfunction, Int. J. Biochem. Cell Biol., 44, 808, 10.1016/j.biocel.2012.02.005 M.R., 2012, RPE cell senescence: a key contributor to age-related macular degeneration, Med. Hypotheses, 78, 505, 10.1016/j.mehy.2012.01.018 Beatty, 2000, The role of oxidative stress in the pathogenesis of age-related macular degeneration, Surv. Ophthalmol., 45, 115, 10.1016/S0039-6257(00)00140-5 Penfold, 2001, Immunological and aetiological aspects of macular degeneration, Prog. Retin. Eye Res., 20, 385, 10.1016/S1350-9462(00)00025-2 Witmer, 2003, Vascular endothelial growth factors and angiogenesis in eye disease, Prog. Retin. Eye Res., 22, 1, 10.1016/S1350-9462(02)00043-5 Ishida, 2004, Regulated expression of apolipoprotein E by human retinal pigment epithelial cells, J. Lipid Res., 45, 263, 10.1194/jlr.M300306-JLR200 Johnson, 2011, Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration, Proc. Natl. Acad. Sci. U. S. A., 108, 18277, 10.1073/pnas.1109703108 Nishi, 2002, Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo, J. Biol. Chem., 277, 44548, 10.1074/jbc.M202970200 Goto, 1996, Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B, Mol. Pharmacol., 49, 860 Fishel, 2011, Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth, Mol. Cancer Ther., 10, 1698, 10.1158/1535-7163.MCT-11-0107 Han, 2013, NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity, J. Immunol., 190, 4786, 10.4049/jimmunol.1201809 Chiarini, 2000, Evidence that the bifunctional redox factor / AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina, Cell Death Differ., 7, 272, 10.1038/sj.cdd.4400639 Chiarini LB, 2000, Tissue biology of apoptosis. Ref-1 and cell differentiation in the developing retina, Ann. N. Y. Acad. Sci., 64 Wu, 2010, Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation, Oncogene, 29, 4330, 10.1038/onc.2010.178 Xanthoudakis, 1996, The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice, Proc. Natl. Acad. Sci. U. S. A., 93, 8919, 10.1073/pnas.93.17.8919 Fishel, 2008, Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth, DNA Repair (Amst.), 7, 177, 10.1016/j.dnarep.2007.09.008 Ono, 1994, Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease, Mutat. Res., 315, 55, 10.1016/0921-8777(94)90028-0 Walker, 1994, A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress, Nucleic Acids Res., 22, 4884, 10.1093/nar/22.23.4884 Jiang, 2010, Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression, Cancer Invest., 28, 885, 10.3109/07357907.2010.512816 Hoppe, 2001, Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE, Invest. Ophthalmol. Vis. Sci., 42, 2714 Robbesyn, 2004, Dual role of oxidized LDL on the NF-kappaB signaling pathway, Free Radic. Res., 38, 541, 10.1080/10715760410001665244 O׳Leary, 2012, TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1, PLoS One, 7, e44176, 10.1371/journal.pone.0044176 Diebold, 2010, The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1, Mol. Biol. Cell, 21, 2087, 10.1091/mbc.E09-12-1003 Pendyala S, 2010, Redox regulation of Nox proteins, Respir. Physiol. Neurobiol., 174, 265, 10.1016/j.resp.2010.09.016 Pendyala, 2011, Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter, Free Radic. Biol. Med., 50, 1749, 10.1016/j.freeradbiomed.2011.03.022 Decanini, 2007, Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration, Am. J. Ophthalmol., 143, 607, 10.1016/j.ajo.2006.12.006 Bonello, 2007, Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site, Arterioscler. Thromb. Vasc. Biol., 27, 755, 10.1161/01.ATV.0000258979.92828.bc Cakir, 2005, Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK, Antioxid. Redox Signal, 7, 726, 10.1089/ars.2005.7.726 Rossello, 2012, AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytes, Brain Res., 87, 10.1016/j.brainres.2012.01.017 Ma, 2007, RAGE ligand upregulation of VEGF secretion in ARPE-19 cells, Invest. Ophthalmol. Vis. Sci., 48, 1355, 10.1167/iovs.06-0738 Zhao, 2011, Age-related retinopathy in NRF2-deficient mice, PLoS One, 6 Rezaei, 2008, Modulation of Nrf2-dependent antioxidant functions in the RPE by Zip2, a zinc transporter protein, Invest. Ophthalmol. Vis. Sci., 49, 1665, 10.1167/iovs.07-0959 Bhattacharya, 2012, Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53–Mdm2 association, Invest. Ophthalmol. Vis. Sci., 53, 8350, 10.1167/iovs.12-10495 Kwok, 2004, Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells, Br. J. Ophthalmol., 88, 1590, 10.1136/bjo.2004.044537 Nagineni, 2012, Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration, J. Cell. Physiol., 227, 116, 10.1002/jcp.22708 Smith, 2012, The importance of hypoxia-regulated, RPE-targeted gene therapy for choroidal neovascularization, Adv. Exp. Med. Biol., 269, 10.1007/978-1-4614-0631-0_35 Chen, 2011, IL-17A stimulates the production of inflammatory mediators via Erk1/2, p38 MAPK, PI3K/Akt, and NF-κB pathways in ARPE-19 cells, Mol. Vis., 3072 Ping, 1999, Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene, J. Immunol., 162, 727, 10.4049/jimmunol.162.2.727 Qiao, 2013, APE1/Ref-1 redox inhibitor APX3330 modulates choroidal endothelial cells by transcriptional regulation of NF-κB and STAT3 activity, Abstr. Assoc. Res. Vis. Ophthalmol., 274 Mullins, 2005, Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration, Mol. Vis., 509